← Leaderboards
Bjorn C Knollmann
Georgetown University
$24,293,199
Attributed
$27,172,145
Total exposure
9
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.5M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$27,172,145 · 9
By mechanism
R01$14,199,209 · 5
R35$7,119,600 · 1
T32$5,823,336 · 2
R13$30,000 · 1
Top collaborators
- Franz Josef Baudenbacher4 shared
- Prince Joseph Kannankeril4 shared
- Sabine Huke3 shared
- Dawood Darbar1 shared
- Lufang Zhou1 shared
Others in their field
Top investigators on “Arrhythmia”
- Dan M Roden · Vanderbilt University Medical Center$63,173,998
- Lynn A Sleeper · New England Research Institutes, Inc.$48,939,627
- Donald M Bers · Cincinnati Childrens Hosp Med Ctr$40,886,752
- Russell E Ware · Duke University$30,715,534
- David Herlie Robertson · Vanderbilt University$28,928,663
- Henry R Halperin · Johns Hopkins University$27,245,374
Research focus
ArrhythmiaHeartInheritedBaseFunctional DisorderPredispositionMutationVentricular ArrhythmiaSudden DeathSyndromeVentricularMolecularCessation Of LifePrematureHeart DiseasesResearch StudyAdultCardiacCellsMuscle CellsMouse ModelCalsequestrinIon ChannelAnimal Model
Grant awards (63)
Toward a Mechanism-Based Approach to Treating Cardiac Arrhythmia$1,020,000
R35 · FY2025 · HL · contact PI
Clinical Pharmacology Training Program$737,637
T32 · FY2025 · GM · contact PI
Toward a Mechanism-Based Approach to Treating Cardiac Arrhythmia$999,600
R35 · FY2024 · HL · contact PI
Clinical Pharmacology Training Program$760,588
T32 · FY2024 · GM · contact PI
Toward a Mechanism-Based Approach to Treating Cardiac Arrhythmia$1,020,000
R35 · FY2023 · HL · contact PI
Clinical Pharmacology Training Program$86,906
T32 · FY2023 · GM · contact PI
Toward a Mechanism-Based Approach to Treating Cardiac Arrhythmia$1,020,000
R35 · FY2022 · HL · contact PI
Clinical Pharmacology Training Program$722,023
T32 · FY2022 · GM · contact PI
Toward a Mechanism-Based Approach to Treating Cardiac Arrhythmia$1,020,000
R35 · FY2021 · HL · contact PI
Clinical Pharmacology Training Program$611,296
T32 · FY2021 · GM · contact PI
Toward a Mechanism-Based Approach to Treating Cardiac Arrhythmia$1,020,000
R35 · FY2020 · HL · contact PI
Clinical Pharmacology Training Program$700,024
T32 · FY2020 · GM · contact PI
Toward a Mechanism-Based Approach to Treating Cardiac Arrhythmia$1,020,000
R35 · FY2019 · HL · contact PI
Clinical Pharmacology Training Program$663,170
T32 · FY2019 · GM · contact PI
Toward a Mechanism-Based Approach to Treating Atrial Fibrillation$552,322
R01 · FY2019 · HL · contact PI
Training Program in Ion Channel and Transporter Biology$225,664
T32 · FY2019 · NS · contact PI
Training Program in Ion Channel and Transporter Biology$756
T32 · FY2019 · NS · contact PI
Toward a Mechanism-Based Approach to Treating Atrial Fibrillation$552,322
R01 · FY2018 · HL · contact PI
Pannexin channels in cardiac arrhythmias$367,500
R01 · FY2018 · HL
Training Program in Ion Channel and Transporter Biology$255,545
T32 · FY2018 · NS · contact PI
Training Program in Ion Channel and Transporter Biology$756
T32 · FY2018 · NS · contact PI
Toward a Mechanism-Based Approach to Treating Atrial Fibrillation$552,322
R01 · FY2017 · HL · contact PI
Arrhythmia Mechanisms in Sarcomeric Cardiomyopathies$395,000
R01 · FY2017 · HL · contact PI
Pannexin channels in cardiac arrhythmias$367,500
R01 · FY2017 · HL
Training Program in Ion Channel and Transporter Biology$246,702
T32 · FY2017 · NS · contact PI
Training Program in Ion Channel and Transporter Biology$6,112
T32 · FY2017 · NS · contact PI
Toward a Mechanism-Based Approach to Treating Atrial Fibrillation$470,900
R01 · FY2016 · HL · contact PI
Pannexin channels in cardiac arrhythmias$367,500
R01 · FY2016 · HL
Arrhythmia Mechanisms in Sarcomeric Cardiomyopathies$314,416
R01 · FY2016 · HL · contact PI
Training Program in Ion Channel and Transporter Biology$240,650
T32 · FY2016 · NS · contact PI
Arrhythmia Mechanisms in Sarcomeric Cardiomyopathies$78,084
R01 · FY2016 · HL · contact PI
Toward a Mechanism-Based Approach to Treating Atrial Fibrillation$77,926
R01 · FY2016 · HL · contact PI
2016 Cardiac Regulatory Mechanisms Gordon Research Conference & Gordon Research Seminar$30,000
R13 · FY2016 · AG · contact PI
Toward a Mechanism-Based Approach to Treating Atrial Fibrillation$548,826
R01 · FY2015 · HL · contact PI
Pannexin channels in cardiac arrhythmias$392,500
R01 · FY2015 · HL
Arrhythmia Mechanisms in Sarcomeric Cardiomyopathies$386,612
R01 · FY2015 · HL · contact PI
Calsequestrin in Ventricular Arrhythmia and Sudden Death$221,551
R01 · FY2015 · HL · contact PI
Calsequestrin in Ventricular Arrhythmia and Sudden Death$162,599
R01 · FY2015 · HL · contact PI
Training Program in Ion Channel and Transporter Biology$124,301
T32 · FY2015 · NS · contact PI
Flecainide for Catecholaminergic Polymorphic Ventricular Tachycardia$542,270
R01 · FY2014 · HL
Arrhythmia Mechanisms in Sarcomeric Cardiomyopathies$391,041
R01 · FY2014 · HL · contact PI
Calsequestrin in Ventricular Arrhythmia and Sudden Death$382,200
R01 · FY2014 · HL · contact PI
Training Program in Ion Channel and Transporter Biology$225,495
T32 · FY2014 · NS · contact PI
Flecainide for Catecholaminergic Polymorphic Ventricular Tachycardia$529,860
R01 · FY2013 · HL
Calsequestrin in Ventricular Arrhythmia and Sudden Death$371,280
R01 · FY2013 · HL · contact PI
Training Program in Ion Channel and Transporter Biology$215,711
T32 · FY2013 · NS · contact PI
Flecainide for Catecholaminergic Polymorphic Ventricular Tachycardia$558,542
R01 · FY2012 · HL
Calsequestrin in Ventricular Arrhythmia and Sudden Death$390,000
R01 · FY2012 · HL · contact PI
Arrhythmia Mechanisms in Sarcomeric Cardiomyopathies$378,180
R01 · FY2012 · HL · contact PI
Flecainide for Catecholaminergic Polymorphic Ventricular Tachycardia$560,115
R01 · FY2011 · HL
Arrhythmia Mechanisms in Sarcomeric Cardiomyopathies$382,000
R01 · FY2011 · HL · contact PI
Calsequestrin in Ventricular Arrhythmia and Sudden Death$439,975
R01 · FY2010 · HL · contact PI
Arrhythmia Mechanisms in Sarcomeric Cardiomyopathies$382,000
R01 · FY2010 · HL · contact PI
Calsequestrin in Ventricular Arrhythmia and Sudden Death$438,516
R01 · FY2009 · HL · contact PI
Arrhythmia Mechanisms in Sarcomeric Cardiomyopathies$381,100
R01 · FY2009 · HL · contact PI
Calsequestrin in Ventricular Arrhythmia and Sudden Death$437,099
R01 · FY2008 · HL · contact PI
Calsequestrin in Ventricular Arrhythmia and Sudden Death$18,055
R01 · FY2008 · HL · contact PI
Calsequestrin in Ventricular Arrhythmia and Sudden Death$383,438
R01 · FY2007 · HL · contact PI
Troponin T mutations and Sudden Cardiac Death$361,018
R01 · FY2006 · HL · contact PI
Troponin T mutations and Sudden Cardiac Death$202,583
R01 · FY2005 · HL
Troponin T mutations and Sudden Cardiac Death$157,817
R01 · FY2005 · HL
Troponin T mutations and Sudden Cardiac Death$360,400
R01 · FY2004 · HL
Troponin T mutations and Sudden Cardiac Death$343,840
R01 · FY2003 · HL